Skip to content

What is the Newest Birth control Option? A 2025 Look at Contraceptive Innovations

4 min read

In the United States, nearly 80% of women of reproductive age have used oral contraceptive pills [1.2.6]. As science evolves, so do the choices, leading many to ask: what is the newest birth control option for modern family planning?

Quick Summary

An overview of the latest contraceptive methods, including the first-ever over-the-counter pill, a non-hormonal gel, and a year-long vaginal ring. Compares new and existing options for informed decision-making.

Key Points

  • First OTC Pill: Opill is the first daily birth control pill available in the U.S. without a prescription, increasing accessibility [1.2.1].

  • On-Demand & Hormone-Free: Phexxi is a non-hormonal gel that works by maintaining vaginal pH to prevent pregnancy and is used only before intercourse [1.4.1, 1.4.4].

  • Year-Long Convenience: Annovera is a single, reusable vaginal ring that provides contraception for an entire year [1.5.5].

  • Novel Hormones: Pills like Nextstellis (with estetrol) and Slynd (with drospirenone) offer new hormonal formulations designed to improve side effect profiles and dosing flexibility [1.6.3, 1.7.2].

  • Male Contraception Progress: A non-hormonal male birth control pill, YCT-529, has passed initial human safety trials but is not yet available to the public [1.8.1, 1.8.2].

  • Informed Choice is Key: Selecting the right birth control depends on individual health, lifestyle, and preferences, making consultation with a healthcare provider essential [1.9.2, 1.9.4].

In This Article

The landscape of contraception is continually expanding, offering more personalized and convenient methods than ever before. Recent years have seen groundbreaking approvals that shift how people access and use birth control, from the first over-the-counter daily pill to innovative non-hormonal and long-lasting options. Understanding these new choices is key to making an informed decision that aligns with your health, lifestyle, and preferences.

A Landmark in Accessibility: Opill, the First Over-the-Counter Pill

The most significant recent development is the FDA's approval of Opill for nonprescription use, which became available on shelves and online in early 2024 [1.2.1, 1.2.2, 1.2.5]. This marks the first time a daily oral contraceptive has been accessible in the U.S. without a doctor's visit [1.2.1].

Opill is a progestin-only pill (POP), often called a "mini-pill," containing 0.075 mg of the active ingredient norgestrel [1.2.3, 1.3.4]. It works primarily by thickening cervical mucus to block sperm and may also prevent ovulation in some cycles [1.3.4]. Since it contains no estrogen, it is a safe option for many individuals who cannot take combination pills, such as those with high blood pressure, a history of certain blood clots, or smokers over 35 [1.3.1, 1.7.3]. With perfect use—taking it at the same time every day—Opill is 98% effective [1.3.1]. However, typical use effectiveness is around 91% [1.3.6]. The key to its success is consistency; if a pill is taken more than 3 hours late, a backup method like a condom should be used for the next 48 hours [1.3.5].

On-Demand & Hormone-Free: Phexxi Vaginal Gel

For those seeking a non-hormonal, on-demand option, Phexxi (lactic acid, citric acid, and potassium bitartrate) offers a unique approach [1.4.2]. Approved in 2020, Phexxi is a vaginal gel that works by maintaining the vagina's naturally acidic pH level (3.5-4.5) [1.4.5, 1.7.2]. Semen is alkaline and raises the vaginal pH, but Phexxi's buffering agents keep the environment acidic, which immobilizes sperm [1.4.1, 1.4.5].

It is not a spermicide, which works by killing sperm cells [1.4.1]. Phexxi comes in a pre-filled applicator and must be used immediately before or up to one hour before each act of intercourse [1.4.4]. It is not effective if used after sex [1.4.4]. Common side effects can include vaginal burning or itching, yeast infections, and urinary tract infections [1.4.5].

Long-Lasting, User-Controlled Options

Annovera: The One-Year Reusable Ring

Annovera is a flexible, reusable vaginal ring that provides contraception for a full year (13 cycles) [1.5.5]. It contains a combination of a new progestin (segesterone acetate) and estrogen (ethinyl estradiol) [1.5.2, 1.5.6]. Users insert the ring for 21 days, remove it for a 7-day ring-free week (during which a withdrawal bleed occurs), and then reinsert the same ring [1.5.3]. This eliminates monthly trips to the pharmacy associated with other rings like the NuvaRing, which must be replaced every month [1.5.2]. Annovera is slightly thicker but softer than NuvaRing and does not require refrigeration [1.5.2]. With perfect use, it is about 97% effective [1.5.2].

Newer Formulations in Oral Contraceptives

Beyond Opill, other new pills offer different hormonal profiles.

  • Nextstellis: Approved in 2021, Nextstellis is the first and only birth control pill to use a new type of estrogen called estetrol (E4), which is derived from a plant source [1.6.3, 1.6.4, 1.6.6]. It's combined with the progestin drospirenone [1.6.5]. The use of E4 is notable because it has a more selective action in the body, which may lead to different side effect profiles compared to pills using the traditional ethinyl estradiol [1.6.6].
  • Slynd: Approved in 2019, Slynd is a progestin-only pill that uses drospirenone [1.7.1, 1.7.2]. Unlike traditional mini-pills (like the original norethindrone formula), Slynd has a 24/4 dosing schedule (24 active pills, 4 inactive) and a much more forgiving 24-hour missed pill window [1.7.3, 1.7.4]. This makes it more effective at suppressing ovulation and a more reliable option for those who struggle with the strict 3-hour window of older mini-pills [1.7.4, 1.7.5].

Comparison of New Birth Control Options

Method Type Hormones How It's Used Effectiveness (Perfect Use) Prescription?
Opill Progestin-Only Pill (POP) Norgestrel (Progestin) [1.3.4] Daily oral pill, same time each day [1.3.5] 98% [1.3.1] No [1.2.1]
Phexxi Vaginal Gel None (pH modulator) [1.4.3] Applied vaginally up to 1 hr before sex [1.4.4] ~93% (typical use) [1.4.5] Yes [1.4.2]
Annovera Vaginal Ring Segesterone Acetate (Progestin) & Ethinyl Estradiol (Estrogen) [1.5.2] Inserted for 21 days, removed for 7; reusable for 1 year [1.5.3] ~97% [1.5.2] Yes [1.5.2]
Nextstellis Combination Pill Drospirenone (Progestin) & Estetrol (Estrogen) [1.6.5] Daily oral pill (24 active, 4 inactive) [1.6.2] 98% [1.6.4] Yes [1.6.1]
Slynd Progestin-Only Pill (POP) Drospirenone (Progestin) [1.7.1] Daily oral pill (24 active, 4 inactive) [1.7.3] >99% [1.7.1] Yes [1.7.1]

The Future of Contraception: What's on the Horizon?

Research continues to push boundaries, with a strong focus on male contraceptives. The non-hormonal pill YCT-529 has shown promising results in early human clinical trials in 2024 and 2025, demonstrating it is well-tolerated [1.8.2, 1.8.1]. This drug works by blocking a protein essential for sperm production and was 99% effective in preventing pregnancies in mice [1.8.5]. While a significant step, it is still in trials and not yet available to the public [1.8.2]. Other options like a reversible sperm-blocking hydrogel (ADAM) are also in development [1.8.4].

Conclusion

The array of new birth control options provides more tailored choices than ever. The over-the-counter availability of Opill removes significant barriers to access, while methods like Phexxi, Annovera, Nextstellis, and Slynd offer unique benefits related to hormones, usage schedules, and convenience. Choosing the right method is a personal decision that should be made after considering your health history, lifestyle, and family planning goals [1.9.2, 1.9.5]. Consulting with a healthcare provider can help you navigate these options to find the safest and most effective choice for you [1.9.4].


Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.

Find a Health Center (U.S. Department of Health and Human Services)

Frequently Asked Questions

When used perfectly as directed (taken at the same time every day), Opill is 98% effective, which is comparable to prescription progestin-only pills [1.3.1, 1.3.5]. With typical use, its effectiveness is about 91% [1.3.6].

Yes, Phexxi is a non-hormonal contraceptive gel that requires a prescription from a healthcare provider [1.4.2].

When the Annovera ring is removed for the 7-day ring-free period, it should be washed with mild soap and warm water, patted dry, and stored in its provided case away from extreme temperatures [1.5.3].

Nextstellis is the first birth control pill to contain a new type of estrogen called estetrol (E4), which is produced from a plant source and has more selective activity in the body compared to the synthetic estrogens in other pills [1.6.3, 1.6.6].

Slynd has a much more flexible 24-hour missed pill window, whereas traditional progestin-only pills (mini-pills) have a strict 3-hour window. This makes Slynd a more forgiving and reliable option [1.7.3, 1.7.4].

While a non-hormonal pill called YCT-529 has successfully completed early human safety trials, it must still undergo larger, longer-term efficacy studies. There is no confirmed date for public availability, and the process for FDA approval is long [1.8.2, 1.8.5].

No, Opill, like other hormonal contraceptives, does not protect against sexually transmitted infections (STIs). Barrier methods like condoms should be used for STI protection [1.3.1].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.